ATE335809T1 - Il-2 unabhängige t-zellen der katze - Google Patents

Il-2 unabhängige t-zellen der katze

Info

Publication number
ATE335809T1
ATE335809T1 AT00111079T AT00111079T ATE335809T1 AT E335809 T1 ATE335809 T1 AT E335809T1 AT 00111079 T AT00111079 T AT 00111079T AT 00111079 T AT00111079 T AT 00111079T AT E335809 T1 ATE335809 T1 AT E335809T1
Authority
AT
Austria
Prior art keywords
fiv
methods
compositions
subject invention
cats
Prior art date
Application number
AT00111079T
Other languages
English (en)
Inventor
Janet K Yamamoto
Original Assignee
Univ Florida
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida, Univ California filed Critical Univ Florida
Application granted granted Critical
Publication of ATE335809T1 publication Critical patent/ATE335809T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
AT00111079T 1995-08-25 1996-08-23 Il-2 unabhängige t-zellen der katze ATE335809T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51938695A 1995-08-25 1995-08-25

Publications (1)

Publication Number Publication Date
ATE335809T1 true ATE335809T1 (de) 2006-09-15

Family

ID=24068097

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00111079T ATE335809T1 (de) 1995-08-25 1996-08-23 Il-2 unabhängige t-zellen der katze
AT96928989T ATE297218T1 (de) 1995-08-25 1996-08-23 Impfstoff gegen mehrere fiv-subtypen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96928989T ATE297218T1 (de) 1995-08-25 1996-08-23 Impfstoff gegen mehrere fiv-subtypen

Country Status (16)

Country Link
US (5) US5846825A (de)
EP (2) EP1090985B1 (de)
JP (4) JP4142741B2 (de)
KR (2) KR100482616B1 (de)
AT (2) ATE335809T1 (de)
AU (3) AU728750B2 (de)
BR (1) BR9610343A (de)
CA (1) CA2230029C (de)
DE (3) DE69636440D1 (de)
DK (2) DK0848615T3 (de)
ES (2) ES2269042T3 (de)
IL (3) IL123264A0 (de)
NZ (3) NZ502144A (de)
PL (2) PL188041B1 (de)
PT (2) PT848615E (de)
WO (1) WO1997007817A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2230029C (en) * 1995-08-25 2012-03-27 University Of Florida Multi-subtype fiv vaccines
US6254872B1 (en) * 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
US6458528B1 (en) * 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
WO2002067984A2 (en) 2001-02-22 2002-09-06 University Of Florida Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection
EP1385540B1 (de) 2001-05-10 2011-08-24 Wyeth LLC Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
CA2525641A1 (en) 2003-05-12 2004-11-25 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against fiv infection
JP2007505320A (ja) * 2003-09-11 2007-03-08 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
EP1709447B1 (de) 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Verfahren zum nachweis des felinen immunschwächevirus
AU2005215629B2 (en) 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005267605B2 (en) * 2004-06-30 2009-03-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4866848B2 (ja) 2004-06-30 2012-02-01 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルス（ｆｉｖ）のｅｎｖタンパク質のｖ３領域に由来するペプチドの使用を含むｆｉｖを検出するための方法および装置
EP1761555A1 (de) * 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP5409361B2 (ja) 2007-07-25 2014-02-05 北里第一三共ワクチン株式会社 猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
US8596026B2 (en) * 2010-08-05 2013-12-03 Kraft Foods Group Brands Llc Vacuum flow wrap packaging system and method of packaging

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1341439C (en) * 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US6107077A (en) 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
WO1992000098A1 (en) * 1990-06-29 1992-01-09 Daniel Zagury Methods of inducing immune response to aids virus
AU2299892A (en) * 1991-07-05 1993-02-11 Regents Of The University Of California, The Feline lymphoid cell lines capable of producing fiv
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
WO1994020622A1 (en) * 1993-03-11 1994-09-15 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
CA2230029C (en) 1995-08-25 2012-03-27 University Of Florida Multi-subtype fiv vaccines

Also Published As

Publication number Publication date
EP1090985B1 (de) 2006-08-09
JP2007284442A (ja) 2007-11-01
IL123264A0 (en) 1998-09-24
IL163873A0 (en) 2005-12-18
KR19990044093A (ko) 1999-06-25
ES2242967T3 (es) 2005-11-16
NZ316347A (en) 2000-02-28
PL188041B1 (pl) 2004-11-30
US20040067242A1 (en) 2004-04-08
DE69636440T2 (de) 2006-12-21
NZ502144A (en) 2001-09-28
AU2004203358A1 (en) 2004-08-19
JP2013079286A (ja) 2013-05-02
JP5339687B2 (ja) 2013-11-13
US20020172941A1 (en) 2002-11-21
AU772353B2 (en) 2004-04-22
DE69636440T4 (de) 2007-09-27
US5846825A (en) 1998-12-08
ES2269042T3 (es) 2007-04-01
KR100482616B1 (ko) 2005-09-02
US20080145381A1 (en) 2008-06-19
KR20040047812A (ko) 2004-06-05
EP1090985A1 (de) 2001-04-11
BR9610343A (pt) 1999-12-21
DE69634820D1 (de) 2005-07-14
KR100502568B1 (ko) 2005-07-20
IL123264A (en) 2006-09-05
JP4413132B2 (ja) 2010-02-10
ATE297218T1 (de) 2005-06-15
EP0848615B1 (de) 2005-06-08
DK1090985T3 (da) 2006-12-04
DK0848615T3 (da) 2005-10-03
JPH11513031A (ja) 1999-11-09
US7311921B2 (en) 2007-12-25
CA2230029A1 (en) 1997-03-06
PT1090985E (pt) 2006-12-29
PL325376A1 (en) 1998-07-20
AU728750B2 (en) 2001-01-18
PL186706B1 (pl) 2004-02-27
WO1997007817A1 (en) 1997-03-06
JP2005261426A (ja) 2005-09-29
US6447993B1 (en) 2002-09-10
NZ513388A (en) 2006-02-24
JP4142741B2 (ja) 2008-09-03
CA2230029C (en) 2012-03-27
PT848615E (pt) 2005-10-31
AU1972501A (en) 2001-05-03
AU2004203358B2 (en) 2007-10-25
HK1038584A1 (en) 2002-03-22
AU6855596A (en) 1997-03-19
DE69636440D1 (de) 2006-09-21
US6605282B2 (en) 2003-08-12
EP0848615A1 (de) 1998-06-24
DE69634820T2 (de) 2006-03-23

Similar Documents

Publication Publication Date Title
DE69636440D1 (de) IL-2 unabhängige T-Zellen der Katze
Pu et al. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates
PT625053E (pt) Vacina a base de urease contra a infeccao por helicobacter
ES2001752A6 (es) Procedimiento para producir una vacuna de herpesvirus, y para produciruna vacuna multivalente.
NO904538L (no) Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3.
DK437980A (da) Felin infektioest peritonitis-virum og vacciner fremstillet deraf
BRPI0410422A (pt) materiais e processos para para imunização contra infecção por fiv
AU6683400A (en) Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
ES2059305T3 (es) Proteina del virus de la seudorrabia.
AU7680687A (en) Vaccines for fowl colibacillosis
ES2060740T3 (es) Vacunas de virus vivos para la enfermedad de newcastle.
DK506979A (da) Vaccine mod infektioes katte-peritonitis og fremgangsmaade til dens fremstilling
RU2002105550A (ru) Вирусвакцина против инфекционного ларинготрахеита птиц
NZ334154A (en) Cross-protective equine herpes virus (EHV-1) vaccine that protects against EHV-1 and EHV-4 and method of making and using the same
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
Thomson IMMUNOLOGICAL AND PROTECTIVE RESPONSES TO A HERPES SIMPLEX VIRUS SUBUNIT VACCINE IN A LABIAL INFECTION MODEL IN MICE.
MX9709347A (es) Micoplasma synoviae no virulento y vacuna del mismo.
ES2055687T3 (es) Vacuna de virus.
RO82518B1 (ro) Procedeu de obtinere a vaccinului contra bolii lui carre
RU2003100193A (ru) Способ изготовления инактивированной вакцины против синдрома снижения яйценоскости-76 птиц

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1090985

Country of ref document: EP